CUV 3.19% $15.54 clinuvel pharmaceuticals limited

Ann: Appendix 4D Half Yearly Report, page-51

  1. 790 Posts.
    lightbulb Created with Sketch. 1018
    Gotta give Wolgen credit for keeping costs low all these years and building up a bank balance of about $60million. In these uncertain times you wouldn't want to be going cap in hand to the market for more cash - even if successful the dilution would be crazy and would hammer long term holders. I'm comfortable here and know this company will come out the other side ok, they can continue with their US sales negotiations/setup/startup and their other programs like TGA application etc while long termers will hold and wait that bit longer for what we believe is coming. After all we have waited plenty of years already, what's another one or two? Still would like to see CUV board/leadership show some balls and do some buying in this market because I have had a crack.
 
watchlist Created with Sketch. Add CUV (ASX) to my watchlist
(20min delay)
Last
$15.54
Change
0.480(3.19%)
Mkt cap ! $763.6M
Open High Low Value Volume
$15.27 $15.56 $15.05 $567.1K 36.96K

Buyers (Bids)

No. Vol. Price($)
4 61 $15.51
 

Sellers (Offers)

Price($) Vol. No.
$15.54 236 1
View Market Depth
Last trade - 12.54pm 12/07/2024 (20 minute delay) ?
CUV (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.